Mass General Brigham Ventures

Mass General Brigham Ventures is a venture fund that creates and backs early-stage life sciences and digital health companies emerging from the Harvard Medical School-affiliated ecosystem, headquartered in Somerville, Massachusetts. The fund’s stated areas of interest are biotech and digital health, often working with researchers and clinicians within the broader Mass General Brigham system to translate science into commercial companies. AI focus is not formally indicated, but AI-enabled biotech and digital health platforms originating from or partnering with the system are consistent with the fund’s mission.

Investments are made at seed and Series A stages with check sizes between $1M and $5M. Activity is largely U.S.-focused and frequently anchored to intellectual property, clinical relationships, or research collaborations inside Mass General Brigham. Compared to standalone health system funds, MGB Ventures has a notable orientation toward true company creation, often working alongside academic founders, technology transfer, and traditional venture syndicates.

Founders engaging Mass General Brigham Ventures should be prepared to discuss intellectual property posture, clinical or research collaborations, and the realistic path from translational science to a commercial product. AI tools should be tied to defensible scientific or clinical foundations rather than positioned solely as software differentiators. Limited public information is available about partner-by-partner thesis details, so introductions through Mass General Brigham clinicians, technology transfer offices, and seasoned biotech and digital health co-investors are the most credible routes.